(Q38397411)

2 September 2017

title

Cognitive predictors of donepezil therapy response in Alzheimer disease (English)

1 reference

2 September 2017

0 references

6

Howard Chertkow

0 references

Natalie Phillips

4

object named as

Natalie Phillips

0 references

Howard Bergman

3

object named as

Howard Bergman

1 reference

2 September 2017

Daniel Saumier

1

1 reference

2 September 2017

Susan Murtha

2

1 reference

2 September 2017

Natalie Phillips

4

1 reference

2 September 2017

Victor Whitehead

5

1 reference

2 September 2017

publication date

10 May 2007

1 reference

Dementia and Geriatric Cognitive Disorders

2 September 2017

published in

1 reference

2 September 2017

volume

24

1 reference

2 September 2017

issue

1

1 reference

2 September 2017

page(s)

28-35

1 reference

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD.

2 September 2017

cites work

1 reference

21 January 2018

1 reference

A new rating scale for Alzheimer's disease.

21 January 2018

1 reference

Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease

21 January 2018

1 reference

Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease.

21 January 2018

1 reference

Effect of gender and apolipoprotein E genotype on response to anticholinesterase therapy in Alzheimer's disease.

21 January 2018

1 reference

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group

21 January 2018

1 reference

Responder characteristics to a single oral dose of cholinesterase inhibitor: a double-blind placebo-controlled study with tacrine in Alzheimer patients

21 January 2018

1 reference

The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer disease

21 January 2018

1 reference

Response of patients with Alzheimer disease to rivastigmine treatment is predicted by the rate of disease progression

21 January 2018

1 reference

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

The Clock Test: a sensitive measure to differentiate normal elderly from those with Alzheimer disease

21 January 2018

1 reference

Orbital and Dorsolateral Frontal Perfusion Defect Associated With Behavioral Response to Cholinesterase Inhibitor Therapy in Alzheimer's Disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000102569

1 reference

2 September 2017

1 reference